About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
COMPANY NEWS
Company
News
Global Health Ltd.
Change Company
BSE Code
543654
ISIN Demat
INE474Q01031
Book Value
113.50
NSE Code
MEDANTA
Dividend Yield %
0.00
Market Cap
295164.10
P/E
77.61
EPS
14.16
Face Value
2
1 Week
1 Month
3 Months
6 Months
1 Year
26-Nov-2024
Global Health informs about notice of postal ball...
26-Nov-2024
Global Health informs about notice of postal ball...
07-Nov-2024
Global Health informs about board meeting
07-Nov-2024
Global Health surges on getting nod to sign agree...
06-Nov-2024
Global Health gets nod to sign agreement to opera...
06-Nov-2024
Global Health informs about board meeting outcome
16-Sep-2024
Global Health informs about investor meet
27-Aug-2024
Global Health informs about news clarification
26-Aug-2024
Global Health informs about analyst meet
23-Jul-2024
Global Health informs about disclosure
17-Jul-2024
Global Health informs about clarification on news
25-Jun-2024
Global Health submits analyst meet intimation
18-May-2024
Global Health informs about investor presentation
16-Mar-2024
Global Health informs about trading window closure
16-Feb-2024
Global Health submits analyst meet intimation
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.